Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24904 | 248 | 45.9 | 76% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 667 | 12573 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AGOMELATINE | Author keyword | 113 | 60% | 50% | 123 |
| 2 | MELATONERGIC RECEPTORS | Author keyword | 6 | 80% | 2% | 4 |
| 3 | S 20098 | Author keyword | 6 | 71% | 2% | 5 |
| 4 | S20098 | Author keyword | 6 | 100% | 2% | 4 |
| 5 | VALDOXAN | Author keyword | 3 | 50% | 2% | 5 |
| 6 | S32006 | Author keyword | 3 | 100% | 1% | 3 |
| 7 | AGOMELATIN VALDOXAN | Author keyword | 1 | 100% | 1% | 2 |
| 8 | CHRONIC FOOTSHOCK STRESS | Author keyword | 1 | 100% | 1% | 2 |
| 9 | MED SCI STUDY | Address | 1 | 50% | 1% | 2 |
| 10 | THER EUT NEUROPSYCHIAT | Address | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AGOMELATINE | 113 | 60% | 50% | 123 | Search AGOMELATINE | Search AGOMELATINE |
| 2 | MELATONERGIC RECEPTORS | 6 | 80% | 2% | 4 | Search MELATONERGIC+RECEPTORS | Search MELATONERGIC+RECEPTORS |
| 3 | S 20098 | 6 | 71% | 2% | 5 | Search S+20098 | Search S+20098 |
| 4 | S20098 | 6 | 100% | 2% | 4 | Search S20098 | Search S20098 |
| 5 | VALDOXAN | 3 | 50% | 2% | 5 | Search VALDOXAN | Search VALDOXAN |
| 6 | S32006 | 3 | 100% | 1% | 3 | Search S32006 | Search S32006 |
| 7 | AGOMELATIN VALDOXAN | 1 | 100% | 1% | 2 | Search AGOMELATIN+VALDOXAN | Search AGOMELATIN+VALDOXAN |
| 8 | CHRONIC FOOTSHOCK STRESS | 1 | 100% | 1% | 2 | Search CHRONIC+FOOTSHOCK+STRESS | Search CHRONIC+FOOTSHOCK+STRESS |
| 9 | ACUTE BIPOLAR DEPRESSION | 1 | 50% | 0% | 1 | Search ACUTE+BIPOLAR+DEPRESSION | Search ACUTE+BIPOLAR+DEPRESSION |
| 10 | ALLOSTATIC REGULATION | 1 | 50% | 0% | 1 | Search ALLOSTATIC+REGULATION | Search ALLOSTATIC+REGULATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIDEPRESSANT AGOMELATINE | 29 | 75% | 8% | 21 |
| 2 | MELATONIN AGONIST AGOMELATINE | 25 | 70% | 8% | 21 |
| 3 | S 20098 | 23 | 70% | 8% | 19 |
| 4 | MELATONIN AGONIST | 14 | 60% | 6% | 15 |
| 5 | MELATONINERGIC AGONIST | 10 | 73% | 3% | 8 |
| 6 | PLACEBO CONTROLLED DISCONTINUATION | 6 | 80% | 2% | 4 |
| 7 | AGOMELATINE | 6 | 25% | 8% | 21 |
| 8 | DISCONTINUATION SYMPTOMS | 5 | 44% | 3% | 8 |
| 9 | RAT CIRCADIAN RHYTHMS | 4 | 67% | 2% | 4 |
| 10 | RAT PREFRONTAL FRONTAL CORTEX | 4 | 75% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression | 2015 | 3 | 73 | 55% |
| Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials | 2013 | 24 | 29 | 45% |
| A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression | 2011 | 25 | 38 | 63% |
| CASE HISTORY Agomelatine, the first melatonergic antidepressant: discovery, characterization and development | 2010 | 116 | 105 | 30% |
| Agomelatine in depression | 2013 | 7 | 52 | 60% |
| Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties | 2014 | 6 | 138 | 33% |
| Agomelatine Is Effective in Reducing Insomnia in Abstinent Alcohol-Dependent Patients | 2014 | 4 | 15 | 40% |
| The mechanism, efficacy, and tolerability profile of agomelatine | 2014 | 2 | 42 | 55% |
| Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review | 2013 | 9 | 87 | 43% |
| Role of melatonin in mood disorders and the antidepressant effects of agomelatine | 2012 | 16 | 108 | 34% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED SCI STUDY | 1 | 50% | 0.8% | 2 |
| 2 | THER EUT NEUROPSYCHIAT | 1 | 100% | 0.8% | 2 |
| 3 | FORIPSI | 1 | 25% | 1.6% | 4 |
| 4 | PSYCHIAT SERV DIAG TREATMENT | 1 | 19% | 2.0% | 5 |
| 5 | SLEEP MED PROGRAM | 1 | 14% | 2.0% | 5 |
| 6 | EA GRIIOT | 1 | 17% | 1.6% | 4 |
| 7 | ASL TERAMO | 1 | 50% | 0.4% | 1 |
| 8 | ASL TERAMO 4 | 1 | 50% | 0.4% | 1 |
| 9 | COSMIC DISCOVERIES | 1 | 50% | 0.4% | 1 |
| 10 | HOSP G MAZZINI | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000265190 | MELATONIN RECEPTORS//PARS TUBERALIS//IODOMELATONIN |
| 2 | 0.0000152534 | REM LATENCY//RAPID EYE MOVEMENT LATENCY//EEG SLEEP |
| 3 | 0.0000152360 | BRIGHT LIGHT//DELAYED SLEEP PHASE SYNDROME//BIOL RHYTHMS |
| 4 | 0.0000144110 | DISCONTINUATION SYNDROME//DISCONTINUATION SYMPTOMS//WITHDRAWAL REACTIONS |
| 5 | 0.0000135127 | VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM |
| 6 | 0.0000104267 | LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM |
| 7 | 0.0000080140 | SEXUAL DYSFUNCTION//HYPERPROLACTINEMIA//HYPERPROLACTINAEMIA |
| 8 | 0.0000073488 | PINDOLOL//VILAZODONE//NEUROBIOL PSYCHIAT UNIT |
| 9 | 0.0000070998 | KETAMINE//EXPT THER EUT PATHOPHYSIOL BRANCH//INTEGRAT BIOMED BRAIN DIS |
| 10 | 0.0000070096 | MIRTAZAPINE//ORG 3770//C 11MIRTAZAPINE |